NEBBIOSO, Angela
 Distribuzione geografica
Continente #
EU - Europa 9.963
NA - Nord America 4.397
AS - Asia 4.087
SA - Sud America 706
AF - Africa 63
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.229
Nazione #
RU - Federazione Russa 6.335
US - Stati Uniti d'America 4.325
SG - Singapore 1.390
IE - Irlanda 1.055
IT - Italia 870
CN - Cina 869
HK - Hong Kong 678
BR - Brasile 600
VN - Vietnam 490
UA - Ucraina 394
GB - Regno Unito 391
DE - Germania 334
KR - Corea 223
IN - India 122
FI - Finlandia 121
SE - Svezia 113
GR - Grecia 84
TR - Turchia 82
FR - Francia 78
JP - Giappone 55
AR - Argentina 50
NL - Olanda 40
MX - Messico 34
PK - Pakistan 31
CA - Canada 27
BE - Belgio 23
IQ - Iraq 23
ZA - Sudafrica 22
AT - Austria 21
ID - Indonesia 21
PL - Polonia 20
BD - Bangladesh 16
UZ - Uzbekistan 15
EC - Ecuador 14
ES - Italia 14
CO - Colombia 11
HU - Ungheria 11
MA - Marocco 11
VE - Venezuela 9
CL - Cile 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 6
PH - Filippine 6
PT - Portogallo 6
RO - Romania 6
SA - Arabia Saudita 6
TH - Thailandia 6
AL - Albania 5
AZ - Azerbaigian 5
EG - Egitto 5
ET - Etiopia 5
EU - Europa 5
LT - Lituania 5
MY - Malesia 5
NO - Norvegia 5
SI - Slovenia 5
AU - Australia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BO - Bolivia 3
IL - Israele 3
JM - Giamaica 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
BW - Botswana 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
CD - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
LB - Libano 1
LY - Libia 1
MN - Mongolia 1
NG - Nigeria 1
Totale 19.221
Città #
Moscow 2.257
Dublin 1.055
Singapore 715
Hong Kong 669
Santa Clara 613
Jacksonville 604
Chandler 499
San Jose 417
Seoul 211
Ashburn 184
Beijing 180
Caserta 172
Ho Chi Minh City 147
Princeton 132
Medford 116
Hefei 113
Hanoi 112
Ann Arbor 99
Naples 97
Boardman 91
Roxbury 85
Bengaluru 64
Wilmington 64
Munich 63
Bremen 62
São Paulo 62
The Dalles 59
New York 57
San Mateo 52
Napoli 42
Dallas 39
Los Angeles 35
Woodbridge 34
Cambridge 33
Da Nang 33
Orem 31
Rio de Janeiro 31
Aversa 30
Dong Ket 30
Rome 30
Des Moines 29
Milan 26
Nuremberg 26
Haiphong 24
Brussels 23
Nanjing 23
Mountain View 21
Amsterdam 20
Jinan 17
Norwalk 17
Warsaw 17
Düsseldorf 16
Frankfurt am Main 16
Redwood City 16
Giugliano in Campania 15
Salvador 15
Biên Hòa 14
Tianjin 14
Turku 14
Boston 13
Guangzhou 13
Tashkent 13
Vienna 13
Brooklyn 12
London 12
Chennai 11
Ercolano 11
Ferrara 11
Houston 11
Lappeenranta 11
Belo Horizonte 10
Buenos Aires 10
Changsha 10
Council Bluffs 10
Hangzhou 10
Helsinki 10
Hillsboro 10
Nanchang 10
Thái Nguyên 10
Auburn Hills 9
Hải Dương 9
Johannesburg 9
Mexico City 9
Mumbai 9
St Petersburg 9
Atlanta 8
Baghdad 8
Brasília 8
Chicago 8
Florence 8
Istanbul 8
Jakarta 8
Paris 8
Pomigliano d'Arco 8
Porto Alegre 8
Thái Bình 8
Viterbo 8
Cicciano 7
Falls Church 7
Fortaleza 7
Totale 10.174
Nome #
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 205
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondria! Function and Exhibit Inhibition of Proliferation in Cancer Cells 204
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 198
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin 194
1,3,4-oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. 181
Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis 176
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 174
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 170
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 168
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 167
ATTIVITÀ ANTI-PROLIFERATIVA E DIFFERENZIANTE INDOTTA DAL FRUTTO DI PSIDIUM GUAJAVA IN CELLULE LEUCEMICHE UMANE 164
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 163
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 162
The clinical value of HDAC2 and the p53-dependent signalling pathway in colorectal cancer 160
Combined HAT/EZH2 modulation leads to cancer-selective cell death 160
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 159
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells 158
Characterization of Histone Acetyltransferase-1 in cancer cells 158
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 157
APOPTOSI INDOTTA DALL' ESTRATTO TOTALE ACETONICO DEL FRUTTO DI FEIJOA SELLOWIANA (BERG) IN CELLULE LEUCEMICHE UMANE 155
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 155
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 155
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 154
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 152
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 150
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol 149
ATTIVITA’ ANTITUMORALE DEL FLAVONE NATURALE PURIFICATO DA FEIJOA SELLOWIANA IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 149
Comparative phytochemical characterization, genetic profile, and antiproliferative activity of polyphenol-rich extracts from pigmented tubers of different solanum tuberosum varieties 148
Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer 144
The m6A-independent role of epitranscriptomic factors in cancer 141
"Stockpile" of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells 141
3-Chloro-N '-(2-hydroxybenzylidene)benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy 141
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 140
ATTIVATORI DI SIRTUINE E LORO USI 140
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 139
Acute myeloid leukemia: Therapeutic impact of epigenetic drugs 138
The Role of Ozone Carried by Liposomes in the Therapy of Infectious and Skin-Regenerating Ocular Surface 138
Natural compounds in epigenetics: A current view. 136
AZIONE "TUMORE-SELETTIVA" DEGLI INIBITORI DELLE ISTONE DEACETILASI IN LEUCEMIE MIELOIDI ACUTE 136
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. 136
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathway. 136
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 135
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer 134
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity 133
Designing Novel Dual Transglutaminase 2 / Histone Deacetylase Inhibitors Effective in Halting Neuronal Death 133
Developing novel non-hydroxamate histone deacetylase inhibitors: The chelidamic warhead 133
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease 133
The role of SAHA in boron uptake: harnessing epigenetic regulation of LAT1 for optimized BNCT 132
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 132
Bispyridinium Dienes, Histone Deacetylase Inhibitors With Selective Activities 131
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 131
Targeting ROS production through inhibition of NADPH oxidases 130
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 130
Gene transactivation and transrepression in myc-driven cancers 129
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 128
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 128
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 128
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability 127
Cancer epigenetics: Moving forward 127
EPIGENETIC MODULATION OF LAT1 EXPRESSION TO ENHANCE OSTEOSARCOMA SENSITIVITY TO BORON NEUTRON CAPTURE THERAPY (BNCT) 125
Identification of NuRSERY, a New Functional HDAC Complex Composed by HDAC5, GATA1, EKLF and pERK Present in Human Erythroid Cells. 124
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia 124
RIPK1-targeting in cancer: modulation of programmed cell death process for cancer treatment 122
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors 121
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 121
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line 121
CBX3 as a prognostic biomarker in lung cancer 119
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors 119
KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches 119
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring. 118
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A 118
Modulators of Sirtuins 117
Sirtuin Inhibitor Cambinol Induces Cell Differentiation and Differently Interferes with SIRT1 and 2 at the Substrate Binding Site 117
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 117
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 116
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells 116
FEIJOA SELLOWIANA DERIVED NATURAL FLAVONE EXERTS ANTI-CANCER ACTION DISPLAYING HDAC INHIBITORY ACTIVITIES 116
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors 115
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin 115
Identification of two New Synthetic Histone Deacetylase Inhibitors that Modulate Globin Gene Expression in Erythroid Cells from Normal Donors and Thalassemic Patients 114
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation 114
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 114
Adipose-tumor crosstalk in colorectal cancer: Identifying (Epi)genetic biomarkers for tumor progression and cachexia 113
Unravelling the impact of the chromobox proteins in human cancers 113
Pyrrole-Based Hydroxamates and 2-Aminoanilides: Histone Deacetylase Inhibition and Cellular Activities 113
N{varepsilon}-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart 113
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 113
SIRT1 Activation by Natural Phytochemicals: An Overview 113
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b. 112
Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome 112
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer 112
Identification and characterization of PKF118-310 as a KDM4A inhibitor 111
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 111
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity 111
Class II (IIa)-Selective Histone Deacetylase Inhibitors: Synthesis and Biological Evaluation of Novel (Aryloxopropenyl)pyrrolyl Hydroxyamides 108
L’ AZIONE TUMORE-SELETTIVA DEGLI INIBITORI DELLE ISTONE-DEACETILASI COINVOLGE L’INDUZIONE DI TRAIL IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 108
Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO 107
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies. 107
Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines. 107
epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors 106
Totale 13.517
Categoria #
all - tutte 62.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021288 0 0 0 0 0 0 0 0 0 120 111 57
2021/2022849 60 12 15 38 279 13 16 24 38 39 59 256
2022/20232.004 161 57 52 159 204 155 1 92 993 14 50 66
2023/2024772 77 26 37 60 240 76 23 25 4 10 69 125
2024/20252.579 32 25 90 78 407 356 454 234 238 282 203 180
2025/202610.581 470 531 497 632 856 5.938 576 454 410 217 0 0
Totale 19.552